Obatala Sciences logo — Driving Diversity in Research. Impacting the Future.

Obatala Sciences

Driving Diversity in Research. Impacting the Future.

Founded 2017 United States New Orleans, United States 13 employees Series A Total: $4.35M Biotechnology, Health Care +1

General Information

Company Name Obatala Sciences
Founded Year 2017
Location United States New Orleans, United States
Employees 13
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Obatala Sciences. To contact Obatala Sciences, visit obatalasciences.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Obatala Sciences compare?

A PDF of Obatala Sciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Obatala Sciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Obatala Sciences

Obatala Sciences aims to bring diversity to the research field with their contract research services and products offered to industry and academia. The company caters to a wide range of clients, including major pharmaceutical companies, US government entities, contract research organizations, non-profit organizations, and academic research laboratories. Founded in 2017 and based in the United States, Obatala Sciences specializes in areas such as obesity, diabetes, energy metabolism, musculoskeletal system biology, and wound healing. Their unique offering, ObaCell™, serves as an exceptional fat tissue model for disease modeling and drug screening. The company's expertise spans proteomics, genomics, functionality, and adipokine secretion, and they also have the capability to form white or brown fat tissue upon request. The latest funding round for the company was a $3.00M Series A investment on 13 October 2022, led by prominent investors including Elevate Capital, être Venture Capital, Benson Capital Partners, Ochsner Lafayette General, and The Hackett Group. Obatala Sciences' commitment to driving diversity in research and their innovative solutions in the biotechnology and healthcare industries make them an attractive prospect for potential investors seeking to support impactful and forward-thinking ventures.

Business keywords: contract research services, research products, pharmaceutical industry, biological research, obesity research, diabetes research, energy metabolism, musculoskeletal system biology, wound healing, disease modeling, drug screening, proteomics, genomics, adipokine secretion, fat tissue modeling

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $3.00M 5
Elevate Capital, être Venture Capital +3
13 Oct 2022
Series A Undisclosed 1
New Orleans Biofund
28 Apr 2022
Series A Undisclosed 1
New Orleans Biofund
15 Feb 2022
Seed Round $1.10M 2
Elevate Capital, Health Innovation Fund
22 Jan 2021
Grant $245.00K 1
National Center for Advancing Translational Sciences (NCATS)
01 May 2019

Obatala Sciences Alternatives & Competitors

View All Alternatives
Obatala Sciences vs
CK Regeon
CK Regeon Korea South

CK Regeon Inc. is a biotechnology-based company aiming to develop First-In-Class drugs with clear MO...

Series B
9 employees
Biotechnology, Health Care
Obatala Sciences vs
bit.bio
bit.bio United Kingdom

The Cell Coding Company

Series C
123 employees
Biotechnology, Health Care
Obatala Sciences vs
Emulate, Inc.
Emulate, Inc. United States

Our Organ-on-a-Chip technology provides a high-fidelity window into the inner workings of human biol...

Series F
71 employees
Biotechnology, Health Care

FAQ About Obatala Sciences

Driving Diversity in Research. Impacting the Future.
Obatala Sciences was founded in 2017.
Obatala Sciences is headquartered in New Orleans, United States.
Obatala Sciences operates in Biotechnology, Health Care and Life Sciences. Its work centres on contract research services, research products, pharmaceutical industry and biological research.
Obatala Sciences has approximately 13 employees.
Obatala Sciences has completed 5 funding rounds, raising a total of $4.35M. The latest funding stage is Series A.
Top alternatives and competitors to Obatala Sciences include CK Regeon, bit.bio, Emulate, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Obatala Sciences and CK Regeon are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Obatala Sciences, https://bouncewatch.com/company/obatala-sciences, updated 19 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes